Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pediatric Exclusivity Incentives Proposed In European Commission Draft Reg

This article was originally published in The Pink Sheet Daily

Executive Summary

The lack of information on pediatric use of drugs remains a problem in Europe, EC's Brunet tells DIA EuroMeeting in Prague. A draft proposal would create a new marketing authorization system and provide data exclusivity to incentivize pediatric studies in off-patent drugs.

You may also be interested in...

U.K. Developing Pediatric Research Initiative Ahead Of EU Legislation

The British regulatory agency’s proposal would offer scientific advice and waive fees for applications that include pediatric data in labeling. An EU-wide regulation on pediatric incentives is not expected before 2006.

Bristol To Name New R&D Head Shortly

Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts